Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma —a retrospective, international, multicentric AGEO study

ConclusionNo additional benefit of adding F to T monotherapy as a maintenance treatment could be observed. Reintroduction of initial therapy at first progression may be a feasible approach to preserve later treatment lines.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research